August 6, 2007
Merck & Co., Inc. and NovaCardia, Inc. have entered into a definitive agreement under which Merck will acquire NovaCardia for US$350 million. NovaCardia is a clinical-stage pharmaceutical company focused on developing drugs to treat major cardiovascular diseases. The company obtained...read more